Scientia Clinical Research
Scientia Clinical Research is an Australian medical center founded in 2016 that conducts healthy volunteer and oncology clinical trials, operating from Randwick with 11-50 employees as a private Phase I trial site.
- Company typePrivate
- Founded2016
- HeadquartersRandwick, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
Scientia Clinical Research firmographics
Firmographics- Name
- Scientia Clinical Research
- Legal name
- Scientia Clinical Research
- Website
- https://scientiaclinicalresearch.com.au
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Scientia Clinical Research is an Australian medical center founded in 2016 that conducts healthy volunteer and oncology clinical trials, operating from Randwick with 11-50 employees as a private Phase I trial site.
- Ownership category
- akta.pro rank
Scientia Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Scientia Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Randwick
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Scientia Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Scientia Clinical Research product offering
Product offeringCore offering
Scientia Clinical Research operates a medical center in Randwick, Australia that conducts healthy volunteer clinical trials and oncology clinical trial services. The organization functions as a clinical research site supporting sponsor-led drug and treatment development studies, with a focus on first-in-human healthy volunteer studies and oncology patient trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthy Volunteer Clinical Trials
- Oncology Clinical Trial Services
Companies that use Scientia Clinical Research
Customer profileIdeal customer profiles1 record
Scientia Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Scientia Clinical Research competitors and assessment
Company assessmentDirect peers
- CMAX Clinical Research: CMAX is an Adelaide-based early-phase clinical trial facility specializing in healthy volunteer Phase 1 studies. It is the closest Australian direct peer to Scientia's healthy volunteer offering, running similar first-in-human pharmacology trials for biotech sponsors.
- Nucleus Network: Nucleus Network operates dedicated Phase 1 clinical trial units in Melbourne and Brisbane focused on healthy volunteer and patient studies (including oncology). It is a direct Australian competitor with similar scope to Scientia's combined healthy volunteer plus oncology offering.
- Linear Clinical Research: Linear Clinical Research is a Perth-based early-phase oncology and healthy volunteer trial unit affiliated with the Harry Perkins Institute. Its combination of first-in-human oncology and Phase 1 healthy volunteer services makes it highly comparable to Scientia's stated dual focus.
- Q-Pharm: Q-Pharm is a Brisbane-based early-phase clinical trial unit conducting Phase 1 healthy volunteer and patient studies. It is a direct Australian Phase 1 peer competing for the same biotech sponsor placements.
Broad incumbents
- Novotech: Novotech is a large Australia-headquartered CRO with deep early-phase and oncology trial expertise across the Asia-Pacific region. While far larger in scale, it competes with Scientia for biotech-sponsored Phase 1 oncology work and provides context on Australia's regional CRO ecosystem.
- IQVIA: IQVIA is the world's largest CRO with extensive Phase 1 and oncology clinical operations globally, including dedicated early-phase units. It represents the upper-end incumbent alternative that biotech sponsors may select over independent sites like Scientia.
- ICON plc: ICON plc is a leading global CRO with strong early-phase and oncology capabilities following its PRA Health Sciences merger. It competes broadly with Scientia for sponsor-mandated Phase 1 oncology study placements through its clinical trial site network.
- Parexel International: Parexel is a global clinical and bioanalytical services provider with deep early-phase and oncology expertise. It is included as a broad incumbent peer representing the full-service CRO alternative to boutique Phase 1 sites like Scientia.
- Charles River Laboratories: Charles River operates an early-discovery and clinical services business including Phase 1 units and bioanalytical capabilities. As a broad incumbent in the early-phase CRO market it competes with independent Phase 1 sites like Scientia for biotech sponsor allocations.
Others
- Scientia Clinical Research Sydney (academic/adjacent): The Randwick precinct (which includes Prince of Wales Hospital, UNSW-affiliated research activity, and the Bright Alliance/UNSW clinical research facilities) is itself an adjacent research ecosystem. Academic Phase 1 groups and university-affiliated clinical trial units in this precinct are adjacent peers, sharing the same Sydney oncology patient catchment and competing for similar investigator-initiated and industry-sponsored early-phase studies.
Market position
Customer concentration
Scientia Clinical Research social profiles
Digital presenceScientia Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scientia Clinical Research leadership team
Management profileNumber of profiles
Scientia Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scientia Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scientia Clinical Research
What does Scientia Clinical Research do?
Scientia Clinical Research operates a medical center in Randwick, Australia that conducts healthy volunteer clinical trials and oncology clinical trial services. The organization functions as a clinical research site supporting sponsor-led drug and treatment development studies, with a focus on first-in-human healthy volunteer studies and oncology patient trials.
Is Scientia Clinical Research a public or private company?
Scientia Clinical Research is a private company. It is classified as unknown and is currently operating.
When was Scientia Clinical Research founded?
Scientia Clinical Research was founded in 2016. It employs 11 to 50 people.
Where is Scientia Clinical Research based?
Scientia Clinical Research is headquartered in Randwick, Australia, in the Oceania region.
Who are Scientia Clinical Research's main competitors?
Direct peers on record are CMAX Clinical Research, Nucleus Network, Linear Clinical Research and Q-Pharm. Broad incumbents are Novotech, IQVIA, ICON plc, Parexel International and Charles River Laboratories. Scientia Clinical Research Sydney (academic/adjacent) is listed as an others.
Does Scientia Clinical Research have an API?
No public API is recorded for Scientia Clinical Research.
What industry is Scientia Clinical Research in?
Scientia Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 621511 and its SIC code is 8011.